The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...
Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.
Dr. Dina Radenkovic, CEO of Gameto, identifies the main contributors to the gap in in women's health innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback